DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION;대구가톨릭대학교산학협력단
发明人:
PARK, Hee Sung,박희성
申请号：
KRKR2018/006334
公开号：
WO2018/230874A1
申请日:
2018.06.04
申请国别(地区):
KR
年份:
2018
代理人:
摘要：
The present invention relates to an anticancer composition containing cervical cancer-derived AMF as an active ingredient. More specifically, as the cervical cancer-derived AMF of the present invention inhibits proliferation of liver cancer, pancreatic cancer, breast cancer, lung cancer, prostate cancer, and colon cancer and has an excellent effect of causing apoptosis, the composition of the present invention containing the cervical cancer-derived AMF as an active ingredient can be used as a therapeutic anticancer agent.La présente invention concerne une composition anticancéreuse contenant un AMF dérivé du cancer du col de l'utérus à titre de principe actif.Plus spécifiquement, l'AMF dérivé du cancer du col de l'utérus selon la présente invention inhibe la prolifération du cancer du foie, du cancer du pancréas, du cancer du sein, du cancer du poumon, du cancer de la prostate, et du cancer du côlon et a un excellent effet d'induction d'apoptose, la composition selon la présente invention le contenant à titre de principe actif peut être utilisée comme agent thérapeutique anticancéreux.본 발명은 자궁경부암 유래 AMF를 유효성분으로 함유하는 항암용 조성물에 관한 것으로, 더욱 상세하게는 본 발명의 자궁경부암 유래 AMF는 간암, 췌장암, 유방암, 폐암, 전립선암 및 대장암의 증식을 억제하고, 세포사멸을 일으키는 효과가 우수하므로, 자궁경부암 유래 AMF를 유효성분으로 함유하는 본 발명의 조성물은 항암치료제로 사용될 수 있다.
